Literature DB >> 12184769

Reactions of a ruthenium(II) arene antitumor complex with cysteine and methionine.

Fuyi Wang1, Haimei Chen, John A Parkinson, Piedad del Socorro Murdoch, Peter J Sadler.   

Abstract

The Ru(II) organometallic antitumor complex [(eta(6)-biphenyl)RuCl(en)][PF(6)] (1) reacts slowly with the amino acid L-cysteine (L-CysH(2)) in aqueous solution at 310 K. Reactions were followed over periods of up to 48 h using HPLC, electronic absorption spectroscopy, LC-ESI-MS, and 1D or 2D (1)H and (15)N NMR spectroscopy. Reactions at a 1 mM/2 mM (Ru/L-CysH(2)) ratio were multiphasic in acidic solutions (pH 5.1) and appeared to involve aquation as the first step. Initially, 1:1 adducts involving substitution of Cl by S-bound or O-bound L-CysH(2), [(eta(6)-biphenyl)Ru(S-L-CysH)(en)](+) (4a) and [(eta(6)-biphenyl)Ru(O-L-CysH(2))(en)](2+) (4b) formed, followed by the cystine adduct [(eta(6)-biphenyl)Ru(O-Cys(2)H(2))(en)](2+) (3), and two dinuclear complexes from which half or all of the chelated ethylenediamine had been displaced, [(eta(6)-biphenyl)Ru(H(2)O)(microS,N-L-Cys)Ru(eta(6)-biphenyl)(en)](2+) (5) containing one bridging cysteine, and [(eta(6)-biphenyl)Ru(O,N-L-Cys-S)(S-L-Cys-N)Ru(eta(6)-biphenyl)(H(2)O)] (6) containing two bridging cysteines. The unusual cluster species [(biphenyl)Ru](8) (7a) was also detected by MS and was more prevalent in reactions at higher L-CysH(2) concentrations. Complex 5 was the dominant product at pH 2-5, but overall, only ca. 50% of 1 reacted with L-CysH(2) in these conditions. The reaction between 1 and L-CysH(2) was suppressed in 50 mM triethylammonium acetate solution at pH > 5 or in 100 mM NaCl. Only 27% of complex 1 reacted with L-methionine (L-MetH) at an initial pH of 5.7 after 48 h at 310 K and gave rise to only one adduct [(eta(6)-biphenyl)Ru(S-L-MetH)(en)](2+) (8).

Entities:  

Year:  2002        PMID: 12184769     DOI: 10.1021/ic025538f

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  18 in total

1.  Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide.

Authors:  Fuyi Wang; Juraj Bella; John A Parkinson; Peter J Sadler
Journal:  J Biol Inorg Chem       Date:  2005-02-26       Impact factor: 3.358

2.  Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity.

Authors:  Fuyi Wang; Abraha Habtemariam; Erwin P L van der Geer; Rafael Fernández; Michael Melchart; Robert J Deeth; Rhona Aird; Sylvie Guichard; Francesca P A Fabbiani; Patricia Lozano-Casal; Iain D H Oswald; Duncan I Jodrell; Simon Parsons; Peter J Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

3.  Interaction of a ruthenium hexacationic prism with amino acids and biological ligands: ESI mass spectrometry and NMR characterisation of the reaction products.

Authors:  Lydia E H Paul; Bruno Therrien; Julien Furrer
Journal:  J Biol Inorg Chem       Date:  2012-07-06       Impact factor: 3.358

4.  Photodissociation of a ruthenium(II) arene complex and its subsequent interactions with biomolecules: a density functional theory study.

Authors:  Hanlu Wang; Nathan J DeYonker; Xiting Zhang; Cunyuan Zhao; Liangnian Ji; Zong-Wan Mao
Journal:  J Mol Model       Date:  2012-06-01       Impact factor: 1.810

5.  Ruthenium-nitrosyl complexes with glycine, L-alanine, L-valine, L-proline, D-proline, L-serine, L-threonine, and L-tyrosine: synthesis, X-ray diffraction structures, spectroscopic and electrochemical properties, and antiproliferative activity.

Authors:  Anna Rathgeb; Andreas Böhm; Maria S Novak; Anatolie Gavriluta; Orsolya Dömötör; Jean Bernard Tommasino; Eva A Enyedy; Sergiu Shova; Samuel Meier; Michael A Jakupec; Dominique Luneau; Vladimir B Arion
Journal:  Inorg Chem       Date:  2014-02-20       Impact factor: 5.165

Review 6.  Unusual DNA binding modes for metal anticancer complexes.

Authors:  Ana M Pizarro; Peter J Sadler
Journal:  Biochimie       Date:  2009-04-01       Impact factor: 4.079

7.  Identification of clusters from reactions of ruthenium arene anticancer complex with glutathione using nanoscale liquid chromatography Fourier transform ion cyclotron mass spectrometry combined with (18)O-labeling.

Authors:  Fuyi Wang; Stefan Weidt; Jingjing Xu; C Logan Mackay; Pat R R Langridge-Smith; Peter J Sadler
Journal:  J Am Soc Mass Spectrom       Date:  2007-12-15       Impact factor: 3.109

8.  Synthesis, Structure, Stability, and Inhibition of Tubulin Polymerization by RuII-p-Cymene Complexes of Trimethoxyaniline-Based Schiff Bases.

Authors:  Sourav Acharya; Moumita Maji; Kallol Purkait; Arnab Gupta; Arindam Mukherjee
Journal:  Inorg Chem       Date:  2019-06-26       Impact factor: 5.165

9.  Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Adv Inorg Chem       Date:  2009-07-07       Impact factor: 3.282

10.  Mechanistic study on substitution reaction of a citrato(p-cymene)Ru(ii) complex with sulfur-containing amino acids.

Authors:  Sen-Ichi Aizawa; Kohei Takizawa; Momoko Aitani
Journal:  RSC Adv       Date:  2019-08-13       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.